Maik Häntschel
- Molecular Medicine top 10%
-
- Immunotherapy and Immune Responses 7
- Oncology top 10%
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 2
-
- vaccines and immunoinformatics approaches 5
-
- Lung Cancer Treatments and Mutations 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
-
- Acute Myeloid Leukemia Research 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Peter BrossartSusanne M. SchmidtJan WiereckyMarius HorgerMartin MüllerWolfram BruggerDaniela DörfelLothar Kanz
- Cited by
- Molecular MedicineImmunologyOncology
- Journals
- Journal of Clinical Medicine (3 papers)Clinical Cancer Research (2 papers)International Journal of Legal Medicine (2 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Maik Häntschel
20 papers receiving 664 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 50
- Immunology 203
- Oncology 253
- Applied Microbiology and Biotechnology 17
- Cancer Research 94
Countries citing papers authored by Maik Häntschel
This map shows the geographic impact of Maik Häntschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maik Häntschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maik Häntschel more than expected).
Fields of papers citing papers by Maik Häntschel
This network shows the impact of papers produced by Maik Häntschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maik Häntschel. The network helps show where Maik Häntschel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maik Häntschel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2021 | 124 | |
| 3 | 2021 | 0 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 39 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 7 | |
| 8 | 2016 | 2 | |
| 9 | 2014 | 74 | |
| 10 | Kombinierte FDG-PET/CT zur Detektion, zum Therapiemonitoring und zur Verlaufskontrolle von granulozytischen Sarkomen – Erste Ergebnisse | 2009 | 21 |
| 11 | 2009 | 28 | |
| 12 | 2008 | 61 | |
| 13 | 2008 | 17 | |
| 14 | 2007 | 38 | |
| 15 | 2006 | 185 | |
| 16 | 2005 | 1 | |
| 17 | 2004 | 47 | |
| 18 | 2003 | 3 | |
| 19 | 1999 | 15 | |
| 20 | 1995 | 11 |
About Maik Häntschel
Maik Häntschel is a scholar working on Immunology, Oncology and Hematology, having authored 21 papers that have together received 684 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (5 papers), Lung Cancer Treatments and Mutations (4 papers), Acute Myeloid Leukemia Research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Lung Cancer Research Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Molecular Medicine (50 citations), Immunology (203 citations) and Oncology (253 citations). Maik Häntschel has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Peter Brossart, Susanne M. Schmidt, Jan Wierecky, Marius Horger, Martin Müller, Wolfram Brugger, Daniela Dörfel, Lothar Kanz, Stephen Schröder and Frank Grünebach. Their work appears in journals such as Journal of Clinical Medicine, Clinical Cancer Research, International Journal of Legal Medicine, Nuklearmedizin - NuclearMedicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.